You can buy an investment whose payoff turns on a court ruling rather than the economy, which is the whole appeal and the whole danger at once.
Key takeaways
- Litigation finance is paying for someone else’s lawsuit in exchange for a slice of what they win, and getting nothing back if the case loses.
- The uncorrelation is the entire pitch: case outcomes turn on evidence and law, not the economic cycle, so measured correlation with equities and bonds sits near zero.
- Exposure reaches investors through a handful of very different vehicles, from the largest listed funder to specialist funds and online platforms, and the market reached roughly USD 20.6 billion in 2025.
- Duration and enforceability risk do the most damage: roughly three in ten cases lose outright, capital can sit locked up for years, and a single appeal voided a USD 16.1 billion judgment in March 2026.
- Suited only to investors who can lock up capital for years, stomach binary case risk, and diversify across a book rather than a single claim.
The 60-Second Version
Litigation finance is the business of paying for someone else’s lawsuit in exchange for a slice of what they win. A funder puts up the legal costs, the claimant keeps their cash for the years the case grinds on, and if the case succeeds the funder takes an agreed cut of the award. If the case loses, the funder typically gets nothing back. That is the whole model, and what makes it interesting is that whether a lawsuit wins turns on evidence and law, not on interest rates or GDP.
That is why serious money treats the category as a diversifier. A verdict does not care what the stock market did last quarter, so the returns are said to sit apart from everything else in a portfolio, and the correlation coefficients with equities and bonds cluster near zero because case outcomes and market cycles run on different clocks (PPB Capital). The global market for funding lawsuits has grown to roughly USD 20.6 billion in 2025 (Research Nester), and the biggest listed funder reports a lifetime 83 per cent return on invested capital on the cases it has concluded. On paper, it is one of the cleanest diversification stories in alternatives.
It is also an asset class where a single ruling can wipe out the industry’s most celebrated position overnight, where roughly three in ten cases lose outright (Legal Funding Journal), and where the money you commit can sit locked up for years with no way to know if it is working until it is over. The model pays through a diversified book, fails one appeal at a time, and reaches an investor through a handful of very different vehicles.
I. What Litigation Finance Actually Is
Litigation finance, sometimes called litigation funding or third-party funding, is the practice of a party with no prior connection to a lawsuit paying its costs in return for a share of the proceeds if it wins. It is outside capital renting a stake in the outcome of a legal claim. The claimant does not repay a loan in the ordinary sense. The funder is buying a slice of a possible future award.
The mechanic that governs everything is non-recourse, which means that if the case loses, the funder has no right to claw its money back from the claimant. On the LexShares platform, for instance, investments are structured so that a losing case returns zero to the investor (LexShares), with no obligation on the claimant to repay. That single feature is what separates litigation finance from lending. A bank wants its principal back whatever happens. A litigation funder has tied its capital to the merits of the claim itself. The upside is a share of the award, the downside is total loss of that particular investment, and there is very little in between.
Because the funder only gets paid out of a win, the pricing reflects that binary risk. Commercial funders typically take somewhere between 15 and 40 per cent of the recovery (Amicus Capital), a percentage-of-proceeds model rather than the “two-and-twenty” management-fee-plus-carry structure familiar from hedge funds. The wide range tracks how risky the case looks, how long it is likely to run, and how much capital it will swallow before resolution. A strong claim that settles quickly costs the claimant less of the pie. A marginal claim heading for a jury costs more.
It helps to be precise about what is being funded, because “litigation finance” covers several very different things. Single-case commercial funding is a company with a strong claim it cannot afford to pursue, or does not want on its own balance sheet, selling a stake to a funder. Portfolio funding is a funder financing a whole book of cases from a law firm or a corporate claimant, spreading the binary risk across many outcomes so the winners carry the losers. Consumer funding of personal-injury and mass-tort claims is a distinct and more retail-flavoured world again. When institutional investors talk about litigation finance as an asset class, they usually mean the commercial and portfolio end, and that is what the sections that follow concentrate on.
II. Market History and Growth
The modern industry is young, and its birth was a legal event rather than a financial one. For centuries, funding someone else’s lawsuit for a share of the winnings was not merely frowned upon. It was a crime. The doctrines were champerty and maintenance, medieval English rules where maintenance meant meddling in another’s litigation and champerty meant funding it in return for a share of the proceeds. Those doctrines, and their gradual dismantling across the common-law world, are the reason the asset class exists at all, because there was no industry to build while the activity remained a crime.
The change happened in Australia. Commercial litigation funding in its recognisable modern form originated there in the mid-1990s, after New South Wales abolished the criminal offences of maintenance and champerty in 1993. The turning point came a decade later. In 2006 the High Court of Australia, in Campbells Cash and Carry v Fostif, ruled that third-party funding was legitimate and not an abuse of process. Once the highest court in a major common-law jurisdiction had endorsed the model, capital had a template it could follow into other markets.
From there the industry professionalised and, crucially, listed. The firm now called Omni Bridgeway traces back to IMF Bentham, founded in 2001 and one of the oldest listed funders in the world, renamed in March 2020. Burford Capital, today the largest pure-play funder, was itself born on a public market rather than a private one: it floated on London’s AIM market in October 2009, raising USD 130 million, which made it one of the first listed legal-finance firms anywhere (Wikipedia). It then took the model to the deepest capital markets on earth, adding a New York Stock Exchange listing in 2020. Its chief executive describes it as the only litigation finance firm either publicly listed on the New York Stock Exchange or accessing the US public debt markets (Burford Q2 2025 call). A firm that began life on a junior London market and now anchors a NYSE listing marks how far the model has travelled.
The growth numbers now match the maturation, though the sizing is contested, as the data-quality note further down sets out. The global litigation funding investment market reached roughly USD 20.6 billion in 2025 and is projected to grow to around USD 49.2 billion by 2035, a compound annual growth rate near 14.2 per cent (Research Nester). A separate vendor sizes it differently, at roughly USD 25.1 billion in 2025 rising to USD 56.2 billion by 2034 (Custom Market Insights), which is why a careful analyst quotes a range rather than a single figure.
The US commercial market is the best-measured, so it gives the clearest picture. As of the most recent industry census, there were 39 active funders holding USD 15.2 billion in assets under management, committing USD 2.7 billion to new agreements in 2023, down from 44 funders the prior year, an early sign of consolidation. And the shape of that capital is shifting. US law firms took a 35 per cent share of total new funding commitments in 2023, up from 28 per cent the year before (US GAO), evidence of a structural move away from one-off case funding towards financing whole portfolios and law firms.
III. The Demand Drivers
Three forces are pulling capital into this asset class at once, and they reinforce one another.
Legal costs keep rising, and claims outlive the capital to fund them. Major commercial litigation is expensive and slow. A company with a genuinely strong claim can find itself unable, or simply unwilling, to spend millions and wait years to realise it, especially when that spend sits on its own profit-and-loss account as a cost with an uncertain payoff. Litigation funding solves a real problem. It lets the claim be pursued without the claimant carrying the cost or the risk on its own books. The named growth drivers include exactly this, rising legal costs, alongside the appetite for uncorrelated assets and the loosening of the old champerty restrictions.
Institutions want returns that do not move with their other holdings. This demand driver is what turned a legal-services niche into an asset class. A large investor holding equities and credit is exposed, ultimately, to the same economic weather across most of the book. An allocation whose payoff depends on a judge’s ruling rather than the business cycle is genuinely different, and that difference has a portfolio value all its own. The appetite for uncorrelated assets is repeatedly named as a core reason capital keeps arriving. That uncorrelation is both the strongest argument for the asset and the claim now under the most pressure, which is why it gets a fuller examination in the macro and dilemma sections.
Regulation liberalised and technology improved underwriting. The dismantling of champerty rules across jurisdictions removed the legal barrier. Legal-analytics technology is starting to sharpen the harder problem, which is picking which cases to fund. The same synthesis that names rising costs and institutional appetite also points to regulatory liberalisation and legal-analytics technology as structural tailwinds. Better data on how comparable cases have resolved does not remove the binary risk of any single case, but it can, in principle, improve a funder’s hit rate across a book, and in a business where a manager loses a meaningful share of its cases, hit rate is everything.
The result of these three forces is a broadening participant base. The buyers were once specialist boutiques. Now the roster runs to family offices, large asset managers, hedge funds, insurers and banks. The money arriving is no longer niche money, and that shift is the clearest evidence that demand has turned structural.
IV. The Players
Litigation finance is concentrated enough that the leading firms and the people running them are worth naming.
The flagship is Burford Capital, the largest pure-play funder and the one that took the model to public markets, dual-listed on the New York and London stock exchanges under the ticker BUR (Burford Q2 2025 call). Its chief executive is Christopher Bogart and its chief investment officer is John Melo, and between them they are the closest thing the industry has to a public face, because Burford’s filings are the most detailed window any outsider has into how the economics actually work. Its results tend to teach the rest of the category something each time they land.
“To generate the 83% return on invested capital, 26% IRR with a weighted average life of two point six years, like how do we do that?… The asymmetry of returns makes this a really attractive asset.”
John Melo, Chief Investment Officer, Burford Capital (Q2 2025 earnings call)
The other listed veteran is Omni Bridgeway, the Australian funder trading on the ASX under the ticker OBL. Descended from IMF Bentham, founded in 2001 and renamed in March 2020, it is one of the oldest listed funders globally, and being born in the jurisdiction that legalised the model first, it carries the longest institutional track record in the business. Where Burford anchors the American and British capital markets, Omni Bridgeway anchors the Australian and international one.
Then there is the access layer that opened the category to individual investors. LexShares is a platform that fractionalises litigation-finance deals, and it has deployed more than USD 100 million since 2014. It is not open to everyone. Its securities offerings are restricted to accredited investors, meaning individual income above USD 200,000 (or USD 300,000 joint), or net worth above USD 1 million (LexShares), but it represents the retail-adjacent frontier of an asset class that was, until recently, purely institutional.
Around these firms sits the broadening buyer base already noted, the family offices, asset managers, hedge funds, insurers and banks now allocating to the space. The industry has a small number of large, sophisticated originators at its centre and a widening ring of capital providers around them. Concentrated expertise at the core with diffuse capital around it is the pattern you would expect of an asset class in the middle of institutionalising.
V. The Geography
Litigation finance is a global business, but it is unevenly distributed, and the geography maps closely onto where the law made it legal first and where the biggest claims are fought.
Australia is the birthplace and, per capita, remains one of the most developed markets. The model originated there in the mid-1990s and was validated by the High Court in 2006 (Harvard CLP). That head start is why one of the two great listed funders, Omni Bridgeway, is Australian, and why Australian class-action practice has been shaped around the availability of third-party capital for longer than anywhere else. It is also a live case study in how quickly the rules can move. In August 2020 the government reclassified funded class actions as managed investment schemes and forced funders to hold an Australian Financial Services Licence (Jones Day), only for a 2022 Federal Court decision, LCM Funding v Stanwell, to unwind that classification and the government to reverse the licensing requirement. The birthplace of the model is also where the regulatory pendulum has swung hardest.
The United States is the largest single market by capital deployed, and the best-measured. The US commercial market holds USD 15.2 billion in assets across 39 funders (US GAO), and it is where the deepest litigation-finance capital markets sit. Burford accesses the US public debt markets precisely because that is where the money is. It is also where the regulatory and tax debates run hottest, because the scale has attracted the scrutiny.
The United Kingdom hosts the other pole of the listed market, through Burford’s London listing, and some of the largest claims in the world. Third-party funding in England and Wales runs on self-regulation rather than a statutory licence: the Association of Litigation Funders, set up in 2011 at the Ministry of Justice’s request, enforces a voluntary code of conduct, though only 16 of an estimated 44 active funders are members and it cannot sanction those outside it. That light-touch settlement was shaken in July 2023, when the Supreme Court’s ruling in PACCAR held that funding agreements calculating the funder’s return as a percentage of damages were likely unenforceable damages-based agreements, throwing existing deals into doubt overnight (White & Case). The government confirmed in December 2025 that it will legislate to reverse the effect of PACCAR and introduce proportionate regulation (Dechert). Alongside that regulatory drama, England hosts genuinely enormous claims: the BHP Mariana dam class action is the largest in British history, a sign that the English courts have become a venue for globally significant, funder-backed litigation.
Beyond these centres, the market is expanding into continental Europe and parts of Asia and the Middle East as jurisdictions weigh their own rules on third-party funding, but the deep, liquid, well-documented markets remain the Australian, American and British ones. For an investor, the geographic pattern is that this asset class concentrates in common-law jurisdictions where champerty has been dismantled and the courts are willing to enforce large awards. Where the law is uncertain, the capital stays thin.
VI. How To Actually Invest
There is no single “buy litigation finance” button, and the vehicle you choose changes the risk more than in almost any other alternative asset. The routes below carry real tickers, structures and costs where they are disclosed.
| Vehicle | Ticker / access | Structure | Access / minimum | What you actually own |
|---|---|---|---|---|
| Burford Capital | NYSE: BUR / LSE: BUR | Listed pure-play funder | Ordinary share dealing | Equity in the largest listed funder, diversified across a book of cases |
| Omni Bridgeway | ASX: OBL | Listed funder | Ordinary share dealing | Equity in one of the oldest listed funders, international case book |
| LexShares | Platform | Fractional single-case / fund deals | Accredited only: income >USD 200k (>USD 300k joint) or net worth >USD 1m | Direct, non-recourse stakes in specific cases |
| Direct fund commitment | Private funds | Closed-end LP fund | Institutional minimums | A diversified portfolio of funded cases via a manager |
| Single-case direct funding | Private agreements | Bilateral contract | Case-specific | A 15-40 per cent stake in one case’s recovery |
The distinction that matters most is between listed equity and direct case exposure. Buying shares in Burford or Omni Bridgeway gives you a stake in a diversified, professionally underwritten book of cases, wrapped in a liquid listed security you can sell any day the market is open. You are trusting the manager’s case selection and inheriting the whole portfolio’s risk, but you are not exposed to any single verdict, and you can get out. The cost is that a listed funder’s share price does not move only with case outcomes. It moves with sentiment, with the market’s mood on the whole sector, and with events like the March 2026 appeal-court ruling, which took 47 per cent off Burford’s share price in a single day (Stockopedia).
Direct case exposure, through a platform like LexShares or a bilateral funding agreement, is the opposite trade. Here you own the actual outcome of a specific claim, non-recourse, with nothing back if it loses. The correlation to markets is at its purest because there is no share price in between, but so is the binary risk, and there is no liquidity at all. Your capital is committed until the case resolves, which can take years. That combination of total-loss risk and multi-year lock-up is why the route is gated to accredited investors (LexShares), and it is the most direct and least forgiving way to hold the asset.
Between the two sits the private fund route, where an institutional investor commits capital to a closed-end fund that a manager deploys across many cases. This is how most large allocators actually access the asset: diversified case selection, professional underwriting, non-recourse economics at the fund level, and a long lock-up. It captures the uncorrelation thesis in its intended form, a portfolio of independent legal outcomes, at the cost of illiquidity and high minimums that keep it out of retail reach.
Fees work differently here from most alternatives. In direct and single-case funding, the funder’s compensation is the 15-40 per cent share of the recovery. There is no separate annual management fee in the hedge-fund sense. The funder is paid out of the win or not at all. In listed equity, you pay nothing but ordinary dealing costs and inherit the funder’s own cost base through its earnings. Working out which cost model a vehicle uses tells you whether you are paying a fee or sharing an outcome, and it is worth establishing before anything else.
VII. Unit Economics: A Worked Example
The multiple of invested capital a concluded case returns is the number the whole asset class turns on. The economics are worth building from the ground up on the disclosed figures and then stress-testing.
Start with the headline. Burford reports a lifetime track record of an 83 per cent return on invested capital and a 26 per cent internal rate of return, at a weighted-average life of roughly 2.6 years on the cases it has concluded (Burford Q2 2025 call). In practical terms, for every USD 100 committed to a case that eventually resolves in the money, the capital comes back as roughly USD 183 in under three years. That is the asymmetry the chief investment officer was describing, a large gain on the winners achieved over a fairly short holding period. These are manager-reported figures on concluded matters, not an audited industry benchmark, a caveat the house standard requires flagging wherever the numbers appear.
The figure left out of the pitch is the losers. A typical fund manager loses roughly 30 per cent of its cases, and a losing case returns nothing under the non-recourse model, so the economics only work at the portfolio level. Imagine ten equal commitments of USD 100 each, USD 1,000 in total. If three lose entirely, those three return zero and USD 300 of your capital is simply gone. The remaining seven winners have to return not just their own capital and profit but enough to cover the three losses and still clear a return on the whole USD 1,000.
Run the arithmetic. If each of the seven winners returns the Burford-implied 1.83x, that is 7 × USD 183 = USD 1,281 back on USD 1,000 committed, a portfolio multiple of about 1.28x, despite each individual winner nearly doubling. The three total losses have eaten most of the winners’ gains. That is why the industry benchmark for a completed litigation-finance fund is a 1.4x to 2.5x multiple of invested capital (Legal Funding Journal): the winners must be big enough, and frequent enough, to carry the dead cases and still deliver a return. The gap between a great fund and a mediocre one is entirely in the hit rate and the size of the wins.
The platform data shows how wide the dispersion can run at the top end. LexShares reports a median IRR of 52 per cent on concluded cases, with 70 per cent of concluded cases returning more than principal (LexShares). A 52 per cent median IRR is an extraordinary number if it holds, but it measures concluded cases only, on a platform, self-reported. It says nothing about the cases still open, the ones that will lose, or the survivorship in the sample. Treat it as the optimistic end of the range, not the expected outcome.
The unit economics come down to this. Each successful case can nearly double your money in under three years. But a large minority of cases return nothing, the winners must carry the losers, and the realistic portfolio outcome sits in the 1.4x-2.5x band. That is good and uncorrelated, but well short of the 83 per cent-per-case number a naive reading of the headline might suggest. What counts is the portfolio multiple net of the losers, and it is a far more sober figure than the one on the brochure.
VIII. Macro Sensitivity
The central claim of this asset class is that it does not have much macro sensitivity. Uncorrelated is not the same as unaffected, though, and it pays to think through how litigation finance behaves across different regimes rather than assuming it floats free of everything.
The theoretical case is strong. Correlation coefficients with equities and fixed income sit near zero because a case’s outcome depends on evidence and law, not on GDP or interest rates. A jury’s verdict does not consult the yield curve. One stress-test anecdote bears this out: during 2008, while equities fell around 37 per cent and investment-grade bonds returned roughly 5 per cent, litigation-finance portfolios reportedly generated mid-teens returns driven by case fundamentals, though that figure is manager-reported and illustrative, not audited, and should be read as a claim rather than a proof.
The academic support goes further. Work published in the Journal of Alternative Investments found litigation finance delivered in-sample returns exceeding 20 per cent annually with limited correlation to other asset areas (PM Research). If that holds out of sample, it is close to the ideal of a diversifier, with high return and low correlation. The regime table below maps how the asset should behave and where the sensitivities actually sit.
| Regime | What happens elsewhere | Expected litigation-finance behaviour | The caveat |
|---|---|---|---|
| Equity bull market | Stocks rise, credit tight-spread | Largely indifferent; returns driven by case outcomes, not the cycle | Listed funders’ share prices can still be dragged by sentiment |
| Recession | Equities fall, defaults rise | Reportedly resilient, mid-teens in 2008, as verdicts don’t track GDP | The 2008 figure is manager-reported, not audited |
| Rising rates | Bonds fall, discount rates up | Return itself unaffected by rates | Longer-duration cases are worth less in present-value terms; capital is locked up longer |
| Stress / crisis | Liquidity dries up | Underlying case value holds; not a forced seller | No liquidity to realise it; you cannot sell a half-finished case |
The sensitivity that deserves the most respect is not on the macro axis at all. It runs to judicial and enforcement outcomes, a different risk from anything in the table, and it is the point the sceptics now press. The CFA Institute’s 2026 warning is that the uncorrelation premise “is now being tested” and that returns may be more sensitive to judicial interpretation, enforceability of contracts, and structural design than the diversification story assumes. The asset is uncorrelated with markets but highly correlated with the behaviour of courts, and courts are their own source of systemic risk, as the case studies bear out.
IX. Tax
A word first: this is not tax advice, and none of it is a substitute for a professional who knows your residence and your circumstances. Alternative Fortune writes for a global audience, so this section stays jurisdiction-neutral and focuses on what to ask rather than what to conclude, because your personal treatment depends entirely on where you are resident and how a given vehicle is structured.
The point to grasp is that in litigation finance the character of the return is contested and structure-dependent. Unlike a dividend or a bond coupon, where the tax character is usually settled, the return on a funding investment can be treated in more than one way depending on how the deal is documented, and that treatment can materially change what you keep. This is unusually live in litigation finance because the industry has actively engineered its structures with tax in mind.
The tension runs like this. Funders commonly structure returns, for example through prepaid forward or derivative contracts, to qualify for capital-gains treatment, whereas the underlying plaintiff’s award is typically taxed as ordinary income. Tax authorities and reform advocates argue that the economic substance of the funding often resembles a loan or business income, which would invite a “substance-over-form” challenge, the principle that tax follows the real economics of a transaction rather than its paperwork. Reform campaigners have gone so far as to call the current treatment a loophole that should be closed.
Three things follow for any investor. The tax character of your return, capital versus ordinary, is not settled, so assume it could be challenged rather than banking on the favourable reading. Because the treatment is structure-driven, the documentation of the specific vehicle you use is what determines your outcome, so read it and have it read by someone qualified. And the area is under active legislative scrutiny, which means the rules that apply when you enter may not be the rules that apply when you exit. In an asset with multi-year lock-ups, that regulatory drift is a real and specific risk. Ask your adviser how your return is characterised, how robust that characterisation is to challenge, and what happens if the law changes mid-case.
X. Case Studies
The same feature that produces the triumphs in this asset class, funding a claim years before it resolves, produces the disasters. The four cases below are best read together for exactly that reason.
Petersen / Eton Park v Argentina (YPF), the celebrated position. This is the case that made litigation finance famous. In September 2023, a US District Court entered judgment of roughly USD 16 billion, USD 14.3 billion for Petersen and USD 1.7 billion for Eton Park, over Argentina’s 2012 seizure of the oil company YPF (SEC filing). Burford was the funder and stood to collect a large share of that award, which had grown to around USD 18 billion with interest by 2025. For years this single position was held up as the proof that litigation finance could generate returns unlike anything else in a portfolio.
The same case, undone on appeal. On 27 March 2026, the US Second Circuit Court of Appeals struck down the USD 16.1 billion judgment against Argentina, and Burford shares fell 47 per cent on the day (Stockopedia). One appellate ruling erased the value of the industry’s most celebrated position, and nearly half the market value of its largest listed player, in a single trading session. A first-instance win is not money in the bank. Duration risk, the years between a favourable judgment and actual collection, and enforceability risk, whether a higher court or a sovereign defendant will ultimately pay, are not footnotes. They decide whether a funded case returns anything. The same funded claim that was the industry’s proudest example became its starkest warning within thirty months.
Pogust Goodhead and the BHP dam, leverage on top of duration. The underlying case is a genuine landmark. The BHP Mariana dam class action is the largest in British history, with more than 620,000 claimants and valued at £36 billion, arising from the 2015 Fundão dam collapse that released 45 million cubic metres of tailings and killed 19 people. On 20 August 2025 the High Court ruled BHP strictly liable, with a damages trial set for October 2026 (Global Legal Post). Even with a landmark liability win in hand, the firm that built the case nearly broke on the economics of getting there.
Pogust Goodhead, the law firm behind the claim, took £450 million from the hedge fund Gramercy, billed as the largest litigation-funding deal in history, then drew a further £65 million, pushing total debt north of USD 1.7 billion. Auditors flagged “material uncertainty” over the firm’s ability to continue as a going concern. It posted pre-tax losses of around £292 million, cut roughly 20 per cent of staff, and saw its founder replaced by a turnaround consultant holding more than 75 per cent control (City AM). This stacks leverage on top of duration. Borrowing heavily to fund cases that take years to pay out means the interest clock runs long before any award lands, and if the timeline slips, the debt can break you before the case rewards you. A winning case did not save the firm’s balance sheet from the cost of waiting for it.
Chevron / Ecuador, the earlier precedent. Before any of the above, there was Lago Agrio. Burford committed to fund the environmental claim against Chevron in Ecuador, a USD 4 million first tranche of a planned roughly USD 15 million commitment (Singer SF), then terminated the funding in 2011, alleging it had been fraudulently misled, and renounced all interest in the case by 2013. This is a different risk again: not duration, not leverage, but adverse selection and fraud at the claim level. A funder can do its diligence and still discover the claim it backed was not what it appeared. When you buy a stake in someone else’s lawsuit, you are also buying their account of it, and that account is not always verifiable in advance.
XI. The Core Constraint
The binding constraint that shapes everything else in litigation finance is the binary, illiquid, multi-year nature of the individual investment. You commit capital, you cannot get it back until the case resolves, and when it resolves you either win a large multiple or lose nearly everything, with very little in between.
That constraint is why the asset only works at the portfolio level. A single case is a coin-flip with a fat tail. At a roughly 30 per cent chance of total loss, no individual case is investable on its own for anyone who cannot afford to lose the stake entirely. Only across a diversified book, where the winners are frequent enough and large enough to carry the losers, does the maths turn into a sensible expected return. Diversification is not a preference here. It is forced by the shape of the individual bet.
The same constraint explains the illiquidity premium the asset is supposed to pay. Your capital is locked for the multi-year life of the cases. Burford’s weighted-average life is around 2.6 years on concluded matters, and many cases run far longer. There is no secondary market to speak of for a half-finished lawsuit. You cannot rebalance out of a bad case, you cannot take profit early on a good one, and you cannot mark it to anything reliable while it is open. Whatever return arrives comes at the end, in a lump. That illiquidity is the price of admission, and it is why the listed vehicles, which let you sell, trade at a different risk profile from the direct exposures, which do not.
Once you understand this constraint the rest of the asset class follows from it. The high headline returns are compensation for the binary risk and the illiquidity. The insistence on diversification is a response to the total-loss rate. The gating to accredited and institutional investors reflects capital that can genuinely be tied up and partly lost. Each of these traces back to the same locked, binary, long-dated shape of the individual investment.
XII. Inside the Asset
What a funder does between writing the cheque and collecting the award is where the returns are made or lost, and it is largely invisible from the outside.
The first job is selection. Because roughly three in ten cases lose and losers return nothing, the funder’s ability to pick winners is the single largest driver of returns. Legal-analytics technology is starting to matter here, since data on how comparable claims have resolved can in principle sharpen the hit rate, but underwriting a lawsuit remains a deeply human judgement about the strength of the evidence, the quality of the lawyers, the character of the defendant, and the likely path through the courts. A funder is, in effect, running a specialist insurance book, pricing legal risk that generalist capital cannot assess.
The second job is duration management. A funded case is a long-dated, uncertain claim, and the funder carries it through years of procedure, appeals and settlement negotiations. The Burford track record of a 26 per cent IRR at a 2.6-year weighted-average life on concluded matters captures the good scenario, a strong return earned over a manageable holding period. The YPF and Pogust Goodhead cases show the bad one: a case that drags, a judgment that gets appealed, an enforcement that stalls. The longer a case runs, the more capital it consumes and the more that capital’s opportunity cost compounds.
The third job is realisation and enforcement, and it is the part the naive model ignores. Winning a judgment is not the same as collecting on it. The Second Circuit voiding a USD 16.1 billion judgment is the extreme version, but the general truth is that the value of a funded case is not locked in until the money is actually in hand, after appeals, after enforcement, after a sovereign or corporate defendant has exhausted its options. A fund’s returns are the product of all three jobs, selecting, waiting, and collecting, and getting any one of them wrong is enough to keep the headline multiples from arriving.
XIII. The Central Dilemma
Every litigation-finance investor has to sit with a tension that does not resolve neatly. The asset’s greatest strength and its greatest weakness are the same feature: its returns depend on courts rather than markets.
That dependence is what makes it uncorrelated. A verdict genuinely does not track the economic cycle, which is why the correlation with equities and bonds sits near zero and why the diversification pitch is real. If you want an asset whose payoff is disconnected from your other holdings, one whose fate rests on evidence and law rather than GDP and rates, this is close to the purest expression available. The low correlation is a structural property of the asset, not a marketing gloss.
That same dependence is the source of the risk that no diversification can fully tame. Courts are their own systemic force. An appeal court can void a USD 16.1 billion judgment and take 47 per cent off a funder’s share price in a day. A change in how judges interpret funding arrangements, as the UK saw when PACCAR made a swathe of agreements unenforceable in a single ruling (White & Case), or in whether contracts are enforceable, or in the tax treatment of the structures, can hit the whole asset class at once. That is the CFA Institute’s warning, that returns may be more sensitive to judicial interpretation, enforceability of contracts, and structural design than the diversification story admits (CFA Institute). You escape market risk only to take on judicial and regulatory risk instead.
You cannot have the uncorrelation without the court dependence, because they are the same thing viewed from two sides. An investor who wants the diversification benefit must accept that the diversifying force, the courts, is itself a concentrated risk that can move the entire asset class in one ruling. No version of litigation finance gives you the low market correlation while removing the judicial exposure, and the YPF file is the proof of it.
XIV. The Next Frontier
The direction of travel for this asset class is visible in the data, and it points towards portfolios, technology, and scrutiny.
The clearest structural shift is from single cases to portfolios and law-firm financing. US law firms took a 35 per cent share of new funding commitments in 2023, up from 28 per cent the prior year, which is the market migrating away from the binary risk of one case towards the smoother risk of a diversified book. Portfolio funding is where the institutional money wants to be, because it turns a series of coin-flips into something closer to an underwriting business with a predictable loss ratio. That share should keep rising as the asset class matures.
A second shift is technology in underwriting. Legal-analytics tools are named among the structural growth drivers, and the logic is straightforward: in a business where hit rate is everything, any edge in predicting which cases resolve favourably compounds directly into returns. This is early, and picking winners in litigation will remain substantially a matter of judgement for a long time, but the funders that build a genuine data advantage in selection should, over a full cycle, pull away from those that do not.
The most consequential shift is regulatory and structural scrutiny, which cuts both ways. The tax treatment is under active legislative attention, the UK is legislating to reverse PACCAR and regulate funding agreements (Dechert), and the broader debate over disclosure, court oversight and the enforceability of funding arrangements is intensifying as the asset class grows large enough to attract it. The CFA Institute frames the moment as an industry at a crossroads (CFA Institute). More regulation could professionalise the space and legitimise it further. It could also compress the returns and unsettle the tax structures the economics rely on. How the rules evolve matters as much as how the funders perform, and a multi-year-lock-up asset is unusually exposed to rules that change while your capital is committed.
XV. Lessons From History
The short history of this asset class already contains its most useful teachings, and each one was paid for in real money.
A first-instance win is not a return. The YPF case delivered a USD 16 billion judgment in 2023 and then had it voided on appeal in March 2026. The value of a case is not the judgment. It is the cash actually collected after every appeal and enforcement step is exhausted. Every experienced funder already knew this, and every new investor learns it the hard way. Do not mark a win to market until the money has arrived.
Leverage and duration do not mix. Pogust Goodhead built a landmark case, won on liability, and still nearly collapsed because it had borrowed more than USD 1.7 billion against cases that take years to pay. In an asset where the payoff is long-dated and uncertain, debt against that payoff is a bet against the clock, and the clock usually wins. An illiquid, long-duration asset is the wrong thing to lever.
Diligence does not eliminate fraud risk. In the Chevron/Ecuador episode Burford committed capital and then terminated in 2011, alleging it had been fraudulently misled. When you fund a claim you are trusting the claimant’s account of it, and that account can turn out to be false in ways no amount of pre-investment work fully reveals. The integrity of the claim is a risk you can reduce but not underwrite away.
A market’s size is contested even by its own vendors. Estimates for 2025 run from USD 20.6 billion to USD 25.1 billion across the two main vendor reports, and Bloomberg Law has separately argued the often-quoted USD 85 billion figure is overstated (Bloomberg Law). In a young, opaque market a single confident number, especially a large one, is usually false precision, so treat the sizing as a range and be sceptical of anyone who quotes it to the decimal.
XVI. The Case For It
Set the caveats aside for a moment, and the bull case stands on three strong legs.
The diversification is real and hard to replicate. There are not many assets whose returns genuinely do not track markets. Litigation finance is one of them, and the reason is structural rather than statistical. A verdict is decided by evidence and law, so the correlation with equities and bonds sits near zero by construction rather than by luck. Academic work backing returns above 20 per cent annually with limited correlation points at the profile a portfolio builder wants, high return alongside low correlation, and a return stream like that is rare if it holds.
The returns, at the portfolio level, are attractive. The largest listed funder’s lifetime 83 per cent return on invested capital and 26 per cent IRR on concluded cases, and the industry benchmark of 1.4x-2.5x invested capital for completed funds, describe a category that can genuinely compensate its investors for the risk they take, provided the manager can pick cases. Even discounting the manager-reported figures heavily, the after-loss portfolio maths lands somewhere respectable.
The asset class is institutionalising, which reduces some risks. The buyer base has broadened from boutiques to family offices, asset managers, hedge funds, insurers and banks (Katch), the market has grown to roughly USD 20.6 billion, and the largest players are now listed on major exchanges with the disclosure that listing demands (Burford Q2 2025 call). An asset class with public filings, institutional participants and a decade-plus track record is more knowable than the private-boutique niche it grew out of, and you can now see inside it in a way that was not possible ten years ago.
Taken together, litigation finance offers a genuinely differentiated return stream, at attractive portfolio-level multiples, in an asset class that is growing up. For an investor whose problem is that everything they own moves together, that combination is worth taking seriously.
XVII. The Risks
The risks are the other side of the same coin, and in this asset class they are the reason the returns exist rather than a set of footnotes.
Binary loss and no partial credit. Roughly 30 per cent of cases lose outright, and under the non-recourse structure a loss returns nothing. A single-case investor can lose their entire stake on one adverse ruling. This is permanent capital loss, case by case, not volatility that later recovers.
Duration and enforceability risk. A judgment is not cash. The USD 16.1 billion YPF judgment voided on appeal, and the 47 per cent single-day fall it caused, show that the years between winning and collecting are where value is destroyed.
Illiquidity. Direct case exposure locks your capital for the multi-year life of the case with no secondary market. You cannot exit a bad case, and you cannot realise a good one early. Only the listed funders offer liquidity, and they trade with equity-market sentiment rather than pure case exposure.
Leverage risk at the funder or firm level. Borrowing against long-dated, uncertain payoffs nearly broke the firm behind Britain’s largest class action, which ran up more than USD 1.7 billion of debt and faced going-concern doubt despite a winning case. Where a vehicle uses leverage, that risk is yours too.
Fraud and adverse selection. A funder can be fraudulently misled about the claim it is backing, as the Chevron/Ecuador episode showed. The integrity of the underlying claim is a risk that diligence reduces but never removes.
Regulatory and tax uncertainty. The tax character is contested and under active legislative scrutiny (Washington Legal Foundation), the UK’s PACCAR ruling made whole classes of funding agreement unenforceable overnight, and the CFA Institute warns the whole uncorrelation premise is now being tested (CFA Institute). In a multi-year-lock-up asset, rules that change mid-case are a live risk, not a hypothetical one.
Opacity and unverifiable data. The strongest return figures, the 83 per cent ROIC and the 52 per cent median IRR, are manager- and platform-reported, not independently audited, and even the market’s size is contested by its own vendors (Bloomberg Law). You are underwriting an asset class where the headline numbers deserve scepticism.
XVIII. The Alternative Fortune Verdict
Litigation finance is one of the most genuinely differentiated return streams available in alternatives, and also one of the least forgiving. The diversification is worth having; the way you access it decides whether you actually get it or just get the loss rate.
The diversification is real. A verdict does not track the market, the measured correlation with equities and bonds sits near zero, and the portfolio-level economics, a 1.4x-2.5x multiple on completed funds and an 83 per cent lifetime ROIC at the largest listed player, describe an asset that can pay for the risk it carries. The risk is severe and specific. Roughly three in ten cases lose everything, a single appeal can void a USD 16.1 billion judgment overnight, and your capital can be locked and unmarkable for years. The CFA Institute’s own conclusion is worth sitting with:
“The uncorrelation premise… may, in practice, be more sensitive to judicial interpretation, enforceability of contracts, and structural design than previously assumed.”
Joshua J. Myers, CFA, CFA Institute Enterprising Investor, 14 May 2026
Where the edge actually is. The edge in this asset class is not in owning it but in accessing it through diversification you cannot build yourself and manager selection you can actually assess. A single case is a coin-flip an investor should not take. A diversified, professionally underwritten book, whether through a listed funder’s shares or a fund with a real track record, is where the uncorrelation thesis works in its intended form. The edge belongs to the investor who treats case selection as the thing that decides returns, refuses to pay for unaudited headline numbers at face value, and understands that they are buying court exposure rather than market diversification alone. If you cannot get diversified and cannot tolerate a multi-year lock-up with a real chance of loss, the asset is not built for you.
Questions to ask, by vehicle:
- Listed funders (Burford, Omni Bridgeway): How diversified is the case book, and how concentrated is it in any single position, given that the YPF lesson is that one case can move the share price 47 per cent? How much does the share price move with sector sentiment rather than case outcomes, and am I comfortable holding that equity risk on top of the case risk?
- Direct / platform (LexShares and similar): Am I genuinely diversified across enough cases to survive the 30 per cent loss rate, or am I taking single-case binary risk? Do I meet the accredited thresholds, and can I truly tie this capital up until resolution with no exit?
- Private funds: What is the manager’s real, full-sample track record including the losers, not just the concluded-case median? How does the fund use leverage, given the Pogust Goodhead warning? What is the lock-up, and what happens to my commitment if the tax or regulatory rules change mid-life?
- Every vehicle: How is my return characterised for tax, how robust is that characterisation to challenge, and are the return figures I am being shown audited or manager-reported?
The category sits within the wider world of private credit, capital deployed outside public markets in return for a claim on a future payoff, and litigation finance is its most idiosyncratic branch, the one where the payoff depends on a court’s ruling rather than a borrower’s cash flows. The same dependence that makes it uncorrelated is what makes it dangerous, and the edge is real for the investor who takes both of those seriously.
